Agarwal, Shrishti, and Sanchit Mehta. “Food and Drug Administration Gives Breakthrough: Sanctioning of Rezdiffra for Non-Alcoholic Steatohepatitis”. International Journal of Advances in Medicine 12, no. 1 (December 23, 2024): 155–155. Accessed June 10, 2026. https://www.ijmedicine.com/index.php/ijam/article/view/4152.